Goldie R G, D'Aprile A C, Self G J, Rigby P J, Henry P J
Department of Pharmacology, University of Western Australia, Nedlands, Australia.
J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S228-31. doi: 10.1097/00005344-200036051-00068.
Endothelin-1(1-21) (ET-1(1-21)) is a strong candidate as a significant mediator in asthma, in part because of its powerful spasmogenic actions and its ability to enhance cholinergic nerve-mediated contraction in human and animal airway smooth muscle. In the study reported here, we have demonstrated that [125I]ET-1(1-31) binds specifically to BQ-123-sensitive sites (presumably ET(A)-receptors) and to sarafotoxin S6c (S6c)-sensitive sites (presumably ET(B)-receptors) in rat tracheal and pulmonary airways, as well as in lung alveoli. These sites coexist in tracheal airway smooth muscle and in alveolar tissue in approximately equal proportions. ET-1(1-21) and ET-1(1-31) were equipotent and approximately equally active as spasmogens in rat tracheal smooth muscle. Importantly, both peptides were shown to potentiate cholinergic nerve-mediated rat tracheal contraction, although ET-1(1-31) was less active in this regard. These data are consistent with the idea that ET-1(1-31) could play a significant mediator role in obstructive airway diseases such as asthma.
内皮素-1(1-21)(ET-1(1-21))很有可能是哮喘中的一种重要介质,部分原因在于其强大的致痉作用以及它增强人和动物气道平滑肌中胆碱能神经介导收缩的能力。在本文报道的研究中,我们已证明[125I]ET-1(1-31)特异性结合大鼠气管和肺气道以及肺泡中对BQ-123敏感的位点(可能是ET(A)受体)和对蛙皮素S6c(S6c)敏感的位点(可能是ET(B)受体)。这些位点在气管气道平滑肌和肺泡组织中以大致相等的比例共存。ET-1(1-21)和ET-1(1-31)在大鼠气管平滑肌中作为致痉剂的效力相当且活性大致相同。重要的是,尽管ET-1(1-31)在这方面活性较低,但两种肽均显示出增强胆碱能神经介导的大鼠气管收缩的作用。这些数据与ET-1(1-31)可能在诸如哮喘等阻塞性气道疾病中起重要介质作用的观点一致。